Special Issue "Roles, Responsibilities and Duties of the Pharmacist in COVID-19 Management"

A special issue of Pharmacy (ISSN 2226-4787). This special issue belongs to the section "Pharmacy Practice and Practice-Based Research".

Deadline for manuscript submissions: 28 February 2022.

Special Issue Editors

Prof. Dr. Alessandro Bonsignore
E-Mail Website
Guest Editor
Section of Legal and Forensic Medicine, University of Genova, Genova, Italy
Interests: legal and forensic medicine; bioethics; public health; college of physicians; risk management

Special Issue Information

Dear Colleagues,

Since late December 2019, a novel, emerging coronavirus has been identified as the infectious agent responsible for a generally mild but sometimes severe and even life- threatening disease, termed as “coronavirus disease 2019” (COVID-19). The pathogen has been named as “Severe Acute Respiratory Coronavirus type 2” (SARS-CoV-2). COVID-19 quickly spread from the first epicenter, the city of Wuhan, province of Hubei, mainland China, into neighboring countries, and became a global pandemic. COVID-19 has challenged health systems, straining and overwhelming healthcare facilities and settings, including hospital and community pharmacies. On the other hand, the COVID-19 outbreak has unearthed new opportunities for pharmacists: community and hospital pharmacists have, indeed, played a key role during the COVID-19 pandemic, acquiring more professional standing, being authentic frontline health workers.

Prof. Alessandro  Bonsignore
Prof. Nicola Luigi Bragazzi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Pandemic
  • COVID-19
  • Community pharmacists
  • Hospital pharmacists
  • Increased scope of practice
  • Roles, responsibilities, and duties
  • Frontline workers

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Other

Commentary
Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience
Pharmacy 2021, 9(4), 164; https://doi.org/10.3390/pharmacy9040164 - 09 Oct 2021
Viewed by 829
Abstract
Despite numerous challenges in relation to being a recently established school, the University of California, Irvine (UCI) School of Pharmacy and Pharmaceutical Sciences (SPPS), similar to many schools of pharmacy in the United States, was highly committed to supporting the rollout of COVID-19 [...] Read more.
Despite numerous challenges in relation to being a recently established school, the University of California, Irvine (UCI) School of Pharmacy and Pharmaceutical Sciences (SPPS), similar to many schools of pharmacy in the United States, was highly committed to supporting the rollout of COVID-19 vaccines. UCI SPPS and our affiliated UCI Medical Center (UCIMC) Pharmacy Department partnered to spearhead the pharmacy element of a large-scale COVID-19 vaccination clinic on campus for both employees and the community. Three key initiatives were established in order to overcome the obstacles we faced in the large-scale roll out of COVID-19 vaccines: (1) forging new collaborations within the pharmacy team, (2) leveraging interprofessional education and practice, and (3) raising awareness of the pharmacists’ role. Our response to the COVID-19 vaccines at UCI was a tangible, visible model that demonstrated that, while we continue to embrace our role in team-based, patient-centered care, it is also important for us to step up and lead the profession. Additionally, this vaccine rollout experience is a teachable moment for our communities and our health professional partners as we continue to march forward as one voice to serve the American public. Full article
Commentary
In the Eye of the Storm: The Role of the Pharmacist in Medication Safety during the COVID-19 Pandemic at an Urban Teaching Hospital
Pharmacy 2020, 8(4), 225; https://doi.org/10.3390/pharmacy8040225 - 21 Nov 2020
Viewed by 1030
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease (COVID-19) pandemic, has challenged practitioners with complex clinical scenarios as well as conflicting and scarce data to support treatment strategies. The pandemic has also placed strains on institutions [...] Read more.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease (COVID-19) pandemic, has challenged practitioners with complex clinical scenarios as well as conflicting and scarce data to support treatment strategies. The pandemic has also placed strains on institutions due to drug shortages, alterations in medication use processes, economic losses, and staff exposure to the virus. This article provides pharmacist-led suggestions and strategies to various case questions, describing some of the challenges faced by practitioners at an urban teaching hospital during the COVID-19 pandemic. The strategies suggested can be explored at other institutions. Full article

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Title: In the Eye of the Storm: Role of the Pharmacist in Medication Safety During the COVID-19 Pandemic
Authors: Abir O. Kanaan; Karyn M. Sullivan; Sheila M. Seed; Nathan A. Cookson; Linda M. Spooner; George M. Abraham
Affiliation: School of Pharmacy Worcester-Manchester/ MCPHS University
Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the virus responsible for the coronavirus disease (COVID-19) pandemic, has challenged practitioners with complex clinical scenarios as well as conflicting and scarce data to support treatment strategies. The pandemic has also placed strains on institutions due to drug shortages, alterations in medication use processes, economic losses, and staff exposure to the virus. This article provides pharmacist-led suggestions and strategies to various case questions describing some of the challenges faced by practitioners and institutions during the COVID-19 pandemic. The strategies suggested can be applied at other institutions.

Back to TopTop